Kyowa Kirin China Pharmaceutical Co., Ltd.

This study tests a drug called mogamulizumab in 23 Chinese adults with a rare type of skin cancer (mycosis fungoides or Sézary syndrome) that has not responded to prior treatment. The goal is to see if the drug can shrink or eliminate the cancer. Participants receive the drug int…